Insightful Corporation Launches Insightful Clinical Graphics
December 17 2007 - 9:00AM
Business Wire
Insightful Corporation (NASDAQ: IFUL), a leading provider of
predictive analytics and reporting solutions, announced today the
immediate availability of Insightful Clinical Graphics (iCG), a
software and services solution for defining and repurposing
statistical graphics across all functional areas in drug discovery,
development and marketing. With input from multiple life sciences
companies, Insightful designed iCG to simplify the creation and
re-use of statistical graphics and elimination of redundant work
processes. From discovery and pre-clinical and clinical trials,
through marketing and epidemiology, iCG enables scientific data to
be presented as actionable information in clinical study reports,
regulatory submissions, publications and presentations. Today,
highly skilled statistical programming talent is needed to
reprogram, test and QA the numerous statistical graphs used for
analysis and reporting of various studies� data. iCG allows
non-programming statisticians, clinicians and medical writers to
apply customizable graph templates to study data, and to change a
graph style, without compromising the data or the results
displayed. iCG is designed to save pharmaceutical companies time
and to assist in optimizing the deployment of their expensive
statistical programming resources. "Engaging non-technical workers
in the decision-making process and exposing them to the power of
statistical analysis represents a significant market opportunity,"
said Chris Connor, senior research analyst at Health Industry
Insights, an IDC company. "In the life science industry, the
increasing amount of data being generated is becoming
counterproductive. Solutions that can distill data into actionable
information and increase focus across the value chain stand to
fundamentally change the development process." �Insightful Clinical
Graphics reduces the time and resources needed for graphical review
and submission reporting of pre-clinical and clinical data, while
providing consistent information flow between functional areas and
regulatory agencies,� said Dr. Michael O�Connell, Director of Life
Sciences for Insightful. �iCG�s statistical graphics palette and
collaborative platform for graphical analysis enable pharmaceutical
companies to identify safety and efficacy signals sooner, without
burdening their expensive programming assets or risking the
integrity of their analyses.� Insightful Life Sciences Solutions
Provide the Knowledge to Act� Insightful provides life sciences
organizations with the knowledge they need to drive faster, better
decisions, with specialized analytics, graphics and reporting.
Insightful offers software and service solutions in statistical
graphics, PK/PD analysis and reporting, clinical data review,
clinical trial design, and safety data analysis. These solutions
are designed to integrate with existing data management and
workflow systems in exploratory and validated environments, to
speed the analysis and reporting processes and increase the
likelihood of discerning safety and efficacy signals earlier in the
drug development process, thus decreasing customers� product
development costs and time to market. ABOUT INSIGHTFUL Insightful
Corporation (NASDAQ:IFUL) is a provider of predictive analytics and
reporting solutions. Insightful products S-PLUS�, Insightful Miner�
and S-PLUS� Enterprise Server allow companies to perform
sophisticated statistical data analysis and data mining and create
high-quality graphics and reports. Insightful has been delivering
industry-leading, high-ROI solutions to thousands of companies in
financial services, life sciences, telecommunications, and
manufacturing, plus government and research institutions, for 20
years. Headquartered in Seattle, Insightful has offices in New
York, North Carolina, France, Switzerland, and the United Kingdom,
with distributors around the world. For more information, visit
www.insightful.com, email info@insightful.com or call
1-800-569-0123. Note to Investors � Forward Looking Statements This
press release contains forward-looking statements, including
statements about the potential performance and advantages of iCG
and other life sciences solutions and their potential value to
customers. Forward-looking statements are based on the judgment and
opinions of management at the time the statements are made.
Inaccurate assumptions and known and unknown risks and
uncertainties can affect the accuracy of forward-looking
statements. Actual results could differ materially from those
expressed or implied by the forward-looking statements for a number
of reasons, including, without limitation, the risk that our
products do not perform as designed and expected and the risk that
our products do not achieve market acceptance. More detailed
information regarding these and other factors that could affect
actual results is set forth in our filings with the Securities and
Exchange Commission, including our most recent report on Form
10-QSB. You should not unduly rely on these forward-looking
statements, which apply only as of the date of this release. We
undertake no obligation to update publicly any forward-looking
statements to reflect new information, events or circumstances
after the date of this release or to reflect the occurrence of
anticipated events.
Insightful (NASDAQ:IFUL)
Historical Stock Chart
From May 2024 to Jun 2024
Insightful (NASDAQ:IFUL)
Historical Stock Chart
From Jun 2023 to Jun 2024